Compile Data Set for Download or QSAR
Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 8737
TargetAdenosine receptor A2b(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415448(US10428083, Example 59 | 3-Ethyl-1-(2-methoxyethyl...)
Affinity DataKi:  2.40nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415450(US10428083, Example 86 | 3-Isopropyl-1-(2-methoxye...)
Affinity DataKi:  2.70nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415451(US10428083, Example 109 | 3-Ethyl-1-(2-methoxyethy...)
Affinity DataKi:  2.80nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415449(US10428083, Example 66 | 3-Ethyl-5-methyl-1-(oxeta...)
Affinity DataKi:  5.20nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415452(US10428083, Example 113 | 3-Ethyl-5-methyl-6-[(5-o...)
Affinity DataKi:  6.40nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415453(US10428083, Example 116 | 3-Ethyl-5-methyl-6-[(5-o...)
Affinity DataKi:  12nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415451(US10428083, Example 109 | 3-Ethyl-1-(2-methoxyethy...)
Affinity DataKi:  100nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415448(US10428083, Example 59 | 3-Ethyl-1-(2-methoxyethyl...)
Affinity DataKi:  120nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415450(US10428083, Example 86 | 3-Isopropyl-1-(2-methoxye...)
Affinity DataKi:  270nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415449(US10428083, Example 66 | 3-Ethyl-5-methyl-1-(oxeta...)
Affinity DataKi:  280nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415448(US10428083, Example 59 | 3-Ethyl-1-(2-methoxyethyl...)
Affinity DataKi:  330nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415453(US10428083, Example 116 | 3-Ethyl-5-methyl-6-[(5-o...)
Affinity DataKi:  330nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415451(US10428083, Example 109 | 3-Ethyl-1-(2-methoxyethy...)
Affinity DataKi:  590nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415453(US10428083, Example 116 | 3-Ethyl-5-methyl-6-[(5-o...)
Affinity DataKi:  790nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415449(US10428083, Example 66 | 3-Ethyl-5-methyl-1-(oxeta...)
Affinity DataKi:  950nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415450(US10428083, Example 86 | 3-Isopropyl-1-(2-methoxye...)
Affinity DataKi:  1.10E+3nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415452(US10428083, Example 113 | 3-Ethyl-5-methyl-6-[(5-o...)
Affinity DataKi:  1.50E+3nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415452(US10428083, Example 113 | 3-Ethyl-5-methyl-6-[(5-o...)
Affinity DataKi:  1.70E+3nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415453(US10428083, Example 116 | 3-Ethyl-5-methyl-6-[(5-o...)
Affinity DataKi:  3.30E+3nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415449(US10428083, Example 66 | 3-Ethyl-5-methyl-1-(oxeta...)
Affinity DataKi:  6.80E+3nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415448(US10428083, Example 59 | 3-Ethyl-1-(2-methoxyethyl...)
Affinity DataKi:  1.10E+4nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415451(US10428083, Example 109 | 3-Ethyl-1-(2-methoxyethy...)
Affinity DataKi:  1.40E+4nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM415450(US10428083, Example 86 | 3-Isopropyl-1-(2-methoxye...)
Affinity DataKi:  1.60E+5nMAssay Description:The binding properties of the test compounds on adenosine receptors were determined in binding studies with radioligands. For this purpose, membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details
Go to US Patent